Parkman Healthcare Partners LLC Concert Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$4.34 - $5.84 $285,992 - $384,838	65,897 Added 5.79%	1,203,484 $7.03 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $57,709 - $97,308	13,515 Added 1.2%	1,137,587 $7.62 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $2.09 Million - $4.75 Million	746,673 Added 197.85%	1,124,072 $4.73 Million
Q1 2022 May 13, 2022	BUY	$2.73 - $3.94 $1.03 Million - $1.49 Million	377,399 New	377,399 $1.27 Million
Q1 2021 May 14, 2021	SELL	$4.86 - $13.07 $244,409 - $657,290	-50,290 Closed	0 $0

Q4 2020 Feb 12, 2021	BUY	$9.48 - $12.84 $476,749 - $645,723	50,290 New	50,290 $636,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.